PPD Inc. has been recognized for industry leadership in digital and decentralized clinical trial solutions by Information Services Group, according to a news release.

Information Services Group (ISG), a global technology research and advisory firm, recognized PPD as an ISG Provider Lens Leader for digital transformation services, specifically PPD’s clinical development and patient engagement solutions, officials said in the release.

In its 2020 ISG Provider Lens Life Sciences Digital Services Global Report, "ISG recognized PPD with its clinical development designation based on PPD’s strengths in supporting clinical innovation, including deep domain expertise combined with digital knowledge; integration as a focus area; an extensive partner ecosystem; and comprehensive compliance with regulations," stated the release. "The patient engagement recognition is a reflection of PPD strengths in services focused on the patient experience; sophisticated solutions for patient enrollment; and an integrated patient and site education strategy."

“PPD is a clear leader in the move to decentralized clinical trials, a transition that gained additional momentum last year in the face of the pandemic and the need to enhance patient participation and experience,” said Niklas Morton, senior vice president, PPD Digital, in the release. “At the core of ISG’s findings is our ability to create and implement digitally flexible protocols, tailored to the needs of patients, investigators and customers. This, in turn, can provide time and efficiency benefits, as well as advantages in data quality. In today’s challenging environment, our hybrid and decentralized solutions enable risk mitigation to be built into research plans, while allowing study teams to proactively incorporate digital and decentralized solutions into protocols.”

As part of ISG’s Provider Lens designation, PPD received top marks among the 25 service providers ISG assessed across the globe, stated the release.